PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis

English version České info

The H-1 protoparvovirus (H-1PV) is the first replication-competent member of the Parvoviridae family to undergo a phase I/IIa clinical trial in patients suffering from glioblastoma multiforme. Although the intrinsic oncotropism and oncolytic activity of protoparvoviruses are well known, the underlying molecular mechanisms remain elusive. Here we identify a PV-induced intracellular loop-back mechanism that promotes PV replication and cytotoxicity through PI3-kinase-independent stimulation of PDK1 and of the PKC and PKB/Akt1 downstream kinases. This mechanism involves PKCη/Rdx-mediated phosphorylation of PDK1 (at S138 in mouse or S135 in human). Interestingly, this phosphorylation appears as a hallmark of highly aggressive brain tumors. Although H-1PV does not promote it in normal human cells, experimentally administered activated PDK1 variants were able to sensitize these cells to virus infection. These data lead us to propose PDK1phosphoS135 as a new candidate marker for monitoring tumor progression and responsiveness to oncolytic parvovirotherapy, particularly in the case of highly aggressive brain tumors. Furthermore, the sensitivity of PDK1phosphoS135-positive cell lines to inhibitors of PKCη/Rdx argues for considering this complex as a potential target for anticancer drug development.

Vyšlo v časopise: PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis. PLoS Pathog 11(3): e32767. doi:10.1371/journal.ppat.1004703
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004703

Souhrn

Zdroje

1. Hallauer C, Kronauer G, Siegl G (1971) Parvoiruses as contaminants of permanent human cell lines. I. Virus isolation from 1960–1970. Arch Gesamte Virusforsch 35: 80–90. 5167103

2. Geletneky K, Huesing J, Rommelaere J, Schlehofer JR, Leuchs B, et al. (2012) Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. BMC Cancer 12: 99. doi: 10.1186/1471-2407-12-99 22436661

3. Nüesch JPF (2006) Regulation of non-structural protein functions by differential synthesis, modification and trafficking. In: Kerr M.E., CSB; Linden R.M.; Parrish C.R.; Cotmore S.F., editor. Parvoviruses. London: Edward Arnold, Ltd. pp. 275–290.

4. Nuesch JP, Lacroix J, Marchini A, Rommelaere J (2012) Molecular pathways: rodent parvoviruses—mechanisms of oncolysis and prospects for clinical cancer treatment. Clin Cancer Res 18: 3516–3523. doi: 10.1158/1078-0432.CCR-11-2325 22566376

5. Nuesch JP, Rommelaere J (2014) Tumor Suppressing Properties of Rodent Parvovirus NS1 Proteins and Their Derivatives. Adv Exp Med Biol 818: 99–124. doi: 10.1007/978-1-4471-6458-6_5 25001533

6. Lachmann S, Rommeleare J, Nuesch JP (2003) Novel PKCeta is required to activate replicative functions of the major nonstructural protein NS1 of minute virus of mice. J Virol 77: 8048–8060. 12829844

7. Nuesch JP, Lachmann S, Corbau R, Rommelaere J (2003) Regulation of minute virus of mice NS1 replicative functions by atypical PKClambda in vivo. J Virol 77: 433–442. 12477848

8. Lachmann S, Bar S, Rommelaere J, Nuesch JP (2008) Parvovirus interference with intracellular signalling: mechanism of PKCeta activation in MVM-infected A9 fibroblasts. Cell Microbiol 10: 755–769. 18042254

9. Raimondi C, Falasca M (2011) Targeting PDK1 in cancer. Curr Med Chem 18: 2763–2769. 21568903

10. Bayascas JR (2008) Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways. Cell Cycle 7: 2978–2982. 18802401

11. Biondi RM (2004) Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. Trends Biochem Sci 29: 136–142. 15003271

12. Komander D, Fairservice A, Deak M, Kular GS, Prescott AR, et al. (2004) Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J 23: 3918–3928. 15457207

13. Wong KK, Engelman JA, Cantley LC (2010) Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 20: 87–90. doi: 10.1016/j.gde.2009.11.002 20006486

14. Yang KJ, Shin S, Piao L, Shin E, Li Y, et al. (2008) Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding. J Biol Chem 283: 1480–1491. 18024423

15. Newton AC (1997) Regulation of protein kinase C. Curr Opin Cell Biol 9: 161–167. 9069266

16. Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281–294. 17384583

17. Newton AC (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361–371. 12495431

18. Parekh DB, Ziegler W, Parker PJ (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J 19: 496–503. 10675318

19. Schechtman D, Mochly-Rosen D (2001) Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339–6347. 11607837

20. Hoeflich KP, Ikura M (2004) Radixin: cytoskeletal adopter and signaling protein. Int J Biochem Cell Biol 36: 2131–2136. 15313460

21. Yu H, Zhang Y, Ye L, Jiang WG (2011) The FERM family proteins in cancer invasion and metastasis. Front Biosci (Landmark Ed) 16: 1536–1550. 21196246

22. Nuesch JP, Bar S, Lachmann S, Rommelaere J (2009) Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. J Virol 83: 5854–5863. doi: 10.1128/JVI.00039-09 19321616

23. Wick MJ, Wick KR, Chen H, He H, Dong LQ, et al. (2002) Substitution of the autophosphorylation site Thr516 with a negatively charged residue confers constitutive activity to mouse 3-phosphoinositide-dependent protein kinase-1 in cells. J Biol Chem 277: 16632–16638. 11877406

24. Hay S, Kannourakis G (2002) A time to kill: viral manipulation of the cell death program. J Gen Virol 83: 1547–1564. 12075073

25. Di Piazza M, Mader C, Geletneky K, Herrero YCM, Weber E, et al. (2007) Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J Virol 81: 4186–4198. 17287256

26. Lu Z, Cox-Hipkin MA, Windsor WT, Boyapati A (2010) 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol Cancer Res 8: 421–432. doi: 10.1158/1541-7786.MCR-09-0179 20197379

27. Li Y, Yang KJ, Park J (2010) Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer. World J Biol Chem 1: 239–247. doi: 10.4331/wjbc.v1.i8.239 21537480

28. Kaminskyy V, Zhivotovsky B (2010) To kill or be killed: how viruses interact with the cell death machinery. J Intern Med 267: 473–482. doi: 10.1111/j.1365-2796.2010.02222.x 20433575

29. Cornelis JJ, Becquart P, Duponchel N, Salome N, Avalosse BL, et al. (1988) Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. J Virol 62: 1679–1686. 2833618

30. Falasca M, Chiozzotto D, Godage HY, Mazzoletti M, Riley AM, et al. (2010) A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. Br J Cancer 102: 104–114. doi: 10.1038/sj.bjc.6605408 20051961

31. Aeder SE, Martin PM, Soh JW, Hussaini IM (2004) PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 23: 9062–9069. 15489897

32. Shahaf G, Rotem-Dai N, Koifman G, Raveh-Amit H, Frost SA, et al. (2012) PKCeta is a negative regulator of AKT inhibiting the IGF-I induced proliferation. Exp Cell Res 318: 789–799. doi: 10.1016/j.yexcr.2012.01.018 22305966

33. Bar S, Rommelaere J, Nuesch JP (2013) Vesicular Transport of Progeny Parvovirus Particles through ER and Golgi Regulates Maturation and Cytolysis. PLoS Pathog 9: e1003605. doi: 10.1371/journal.ppat.1003605 24068925

34. Nuesch JP, Lachmann S, Rommelaere J (2005) Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice. Virology 331: 159–174. 15582663

35. Nuesch JP, Rommelaere J (2006) NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity. J Virol 80: 4729–4739. 16641266

36. Nuesch JP, Rommelaere J (2007) A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc Natl Acad Sci U S A 104: 12482–12487. 17636126

37. Nuesch JP, Cotmore SF, Tattersall P (1992) Expression of functional parvoviral NS1 from recombinant vaccinia virus: effects of mutations in the nucleotide-binding motif. Virology 191: 406–416. 1413512

38. Bar S, Daeffler L, Rommelaere J, Nuesch JP (2008) Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning. PLoS Pathog 4: e1000126. doi: 10.1371/journal.ppat.1000126 18704167

39. Nuesch JP, Corbau R, Tattersall P, Rommelaere J (1998) Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated In vitro by the phosphorylation state of the polypeptide. J Virol 72: 8002–8012. 9733839

40. Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, et al. (1993) Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci U S A 90: 8342–8346. 8378304